10,887 Shares in CME Group Inc. $CME Bought by MSH Capital Advisors LLC

MSH Capital Advisors LLC bought a new position in CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 10,887 shares of the financial services provider’s stock, valued at approximately $2,404,000.

A number of other institutional investors and hedge funds also recently modified their holdings of CME. Northwestern Mutual Investment Management Company LLC increased its stake in CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after purchasing an additional 37 shares in the last quarter. Rehmann Capital Advisory Group lifted its stake in CME Group by 4.3% during the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after buying an additional 37 shares in the last quarter. Endowment Wealth Management Inc. lifted its stake in CME Group by 4.4% during the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after buying an additional 38 shares in the last quarter. NBT Bank N A NY boosted its holdings in shares of CME Group by 2.3% in the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock worth $492,000 after buying an additional 38 shares during the period. Finally, Resonant Capital Advisors LLC boosted its holdings in shares of CME Group by 3.8% in the first quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock worth $317,000 after buying an additional 39 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Trading Down 1.7%

Shares of NASDAQ CME opened at $266.94 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The business has a 50-day moving average price of $250.89 and a two-hundred day moving average price of $279.81. The firm has a market capitalization of $95.99 billion, a PE ratio of 22.64, a PEG ratio of 3.16 and a beta of 0.23.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.96 EPS. As a group, analysts predict that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group’s payout ratio is presently 44.11%.

Insider Buying and Selling

In related news, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction on Thursday, June 25th. The shares were purchased at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the purchase, the director owned 260,442 shares in the company, valued at $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

CME has been the topic of a number of recent analyst reports. The Goldman Sachs Group cut their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a report on Tuesday, June 30th. Barclays decreased their price objective on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research note on Thursday, July 9th. Deutsche Bank Aktiengesellschaft cut shares of CME Group from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $286.00 to $270.00 in a research report on Wednesday. Raymond James Financial reissued an “outperform” rating and set a $320.00 target price on shares of CME Group in a research note on Thursday, July 2nd. Finally, JPMorgan Chase & Co. increased their target price on CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a report on Thursday, July 23rd. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus target price of $288.56.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.